The mephenytoin (cytochrome P450 2C 19) and dextromethorphan (cytochrome P450 2D6) polymorphisms in Saudi Arabians and Filipinos
- PMID: 7663530
- DOI: 10.1097/00008571-199504000-00002
The mephenytoin (cytochrome P450 2C 19) and dextromethorphan (cytochrome P450 2D6) polymorphisms in Saudi Arabians and Filipinos
Abstract
Hitherto no estimate has been available of the genetic polymorphisms of S-mephenytoin hydroxylation in the Saudi Arabian or any other Middle Eastern population. A total of 102 healthy Saudi Arabian volunteer subjects were tested simultaneously with mephenytoin and dextromethorphan. Two poor metabolizers of S-mephenytoin and two poor metabolizers of dextromethorphan were found. Also 55 healthy Filipino volunteer subjects were tested and 13 found to be poor metabolizers of S-mephenytoin, whilst none were found to be poor metabolizers of dextromethorphan. The Saudi Arabian population thus appears to resemble Europeans in the frequency of poor metabolizers of S-mephenytoin, but resembles Orientals in the frequency of poor metabolizers of dextromethorphan. The Filipino sample as expected resembles other Oriental samples in the frequencies of poor metabolizers of both drugs.
Similar articles
-
Debrisoquin and S-mephenytoin hydroxylation phenotypes and CYP2D6 genotypes in an Estonian population.Pharmacol Toxicol. 1996 May;78(5):303-7. doi: 10.1111/j.1600-0773.1996.tb01379.x. Pharmacol Toxicol. 1996. PMID: 8737964
-
Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations.Pharmacogenetics. 1997 Feb;7(1):59-64. doi: 10.1097/00008571-199702000-00008. Pharmacogenetics. 1997. PMID: 9110363
-
Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism.Br J Clin Pharmacol. 1990 Apr;29(4):373-80. doi: 10.1111/j.1365-2125.1990.tb03653.x. Br J Clin Pharmacol. 1990. PMID: 2328190 Free PMC article. Clinical Trial.
-
[The molecular mechanism of polymorphism of S-mephenytoin hydroxylative metabolism].Sheng Li Ke Xue Jin Zhan. 1995 Jan;26(1):23-8. Sheng Li Ke Xue Jin Zhan. 1995. PMID: 7604218 Review. Chinese.
-
Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.Clin Pharmacokinet. 1995 Sep;29(3):192-209. doi: 10.2165/00003088-199529030-00005. Clin Pharmacokinet. 1995. PMID: 8521680 Review.
Cited by
-
Dextromethorphan metabolic phenotyping in an Iranian population.Eur J Clin Pharmacol. 2005 Feb;60(12):849-54. doi: 10.1007/s00228-004-0859-4. Epub 2005 Jan 19. Eur J Clin Pharmacol. 2005. PMID: 15657780
-
Sex-dependent modulation of treatment response.Dialogues Clin Neurosci. 2004 Mar;6(1):39-51. doi: 10.31887/DCNS.2004.6.1/drubinow. Dialogues Clin Neurosci. 2004. PMID: 22034399 Free PMC article.
-
Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.Drug Saf. 2006;29(9):735-68. doi: 10.2165/00002018-200629090-00001. Drug Saf. 2006. PMID: 16944962 Review.
-
Metabolic capacity of CYP2D6 within an Iranian population (Mazandaran Province).Caspian J Intern Med. 2011 Spring;2(2):213-7. Caspian J Intern Med. 2011. PMID: 24024018 Free PMC article.
-
Distribution of arylamine N-acetyltransferase 2 (nat2) genotypes among Omanis.J Sci Res Med Sci. 2003 Aug;5(1-2):9-14. J Sci Res Med Sci. 2003. PMID: 24019729 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources